Criteria for the use of anti-influenza agents
Kashiwagi, S.
Nihon Rinsho. Japanese Journal of Clinical Medicine 61(11): 1963-1966
2003
ISSN/ISBN: 0047-1852 PMID: 14619439 Document Number: 555302
Amantadine was used from 1998, and two kinds of neuraminidase inhibitors from 2001, in Japan. These anti-influenza agents were recommended to use within 48 hours after the onset of influenza. Because proliferation of influenza virus reaches to peak after two days of the virus infection and the incubation period is only 24 hours. The patients who are after two days of the onset should be treated by only anti-symptomatic therapies.
Document emailed within 1 workday
Related Documents
Lumholtz, I.B. 1981: Drug information: agents for the treatment of arrhythmias. Therapeutic main group: anti-arrhythmia agents. 16. (3). Anti-arrhythmia agents with action on ventricular arrhythmias Sygeplejersken 81(2): 15Zlydnikov, D.M. 1980: Prevention of pneumonia in influenza A by means of a new anti-influenza drug rimantadine Terapevticheskii Arkhiv 52(3): 68-71
Takemoto, T.; Yanai, H. 1988: Drug administration schedule of anti-ulcer agents to prevent recurrence of peptic ulcer; problems on standardization of the appropriate time for the withdrawal of anti-ulcer agents Nihon Rinsho. Japanese Journal of Clinical Medicine 46(1): 133-139
Alvarez-Alva, R. 1971: Epidemiologic study on the 1969-1970 influenza outbreak and the antigenic capacity of anti-influenza vaccine. I. Methodology of the epidemiological studies Gaceta Medica de Mexico 101(1): 21-26
Kubo, S.; Kakuta, M.; Yamashita, M. 2010: In vitro and in vivo effects of a long-acting anti-influenza agent CS-8958 (laninamivir octanoate, Inavir) against pandemic (H1N1) 2009 influenza viruses Japanese Journal of Antibiotics 63(5): 337-346
Spiridonov, V.L.; Akopian, K.A. 2014: Prophylactic use of anti-influenza and anti-pneumococcal vaccines in industrial workers Meditsina Truda i Promyshlennaia Ekologiia 10: 7-11
Cheng, A.C.; Dwyer, D.E.; Kotsimbos, A.Thomas.C.; Starr, M.; Korman, T.M.; Buttery, J.P.; Jenkins, C.R.; Krause, V.L.; Johnson, P.D.R. 2009: Summary of the Australasian Society for Infectious Diseases and the Thoracic Society of Australia and New Zealand guidelines: treatment and prevention of H1N1 influenza 09 (human swine influenza) with antiviral agents Medical journal of Australia 191(3): 142-145
Ernst, J.M. 2000: Who is at risk for influenza? Using criteria other than age Managed Care 9(10): 46 48-50 52-5
Fernández-Viadero, C.; Verduga, R.; Soto, J.; Alsar, M.J. 1993: The use of topical non-steroidal anti-inflammatory agents in elderly patients taking oral anticoagulation agents Medicina Clinica 100(5): 196-197
Lown, J.W. 1988: Lexitropsins: rational design of DNA sequence reading agents as novel anti-cancer agents and potential cellular probes Anti-Cancer Drug Design 3(1): 25-40
Lumholtz, I.B. 1980: Drug information: agents for the treatment of arrhythmias. Therapeutic main group: anti-arrhythmia agents. 14. Digitalis glycosides Sygeplejersken 80(50): 13
Chimirri, A.; Grasso, S.; Montforte, A.M.; Monforte, P.; Zappalà, M. 1994: Anti-HIV agents. III. Synthesis and in vitro anti-HIV activity of novel 1H,3H-thiazolo[3,4-a]imidazo[4,5-b]pyridines Farmaco 49(5): 345-348
Chimirri, A.; Grasso, S.; Monforte, A.M.; Monforte, P.; Rao, A.; Zappalà, M.; Bruno, G.; Nicolò, F.; Scopelliti, R. 1997: Anti-HIV agents. V. Synthesis, structure and in vitro anti-HIV activity of novel 1H,3H-naphtho[2',3':4,5]imidazo[1,2-c]thiazoles Farmaco 52(11): 673-677
Tian, S.L.; Zhao, S.W.; Zhu, A.T.; Fang, Y.; Li, K.Q. 1993: Studies on anti-tumor agents. I: Synthesis and anti-cancer activity of amino acid derivatives of norcantharidin Yao Xue Xue Bao 28(11): 870-875
Fukuchi, S. 1988: Drug administration schedule of anti-ulcer agents to prevent recurrence of peptic ulcer; administration of synergistic drugs for protective factors in peptic ulcer--criteria of drug selection according to clinical symptoms and administration methods Nihon Rinsho. Japanese Journal of Clinical Medicine 46(1): 119-123
Vashchenko, M.A.; Muravskaia, L.V.; Rudenko, A.A.; Napnenko, E.Ia.; Moĭseenko, L.E. 1977: Criteria of recovery of patients with influenza and primary lesions of the nervous system Vrachebnoe Delo 1977(3): 1-4
Miki, M.; Watanabe, A. 2012: New antiviral agents of influenza Nihon Rinsho. Japanese Journal of Clinical Medicine 70(4): 649-654
Calne, R. 1994: Criteria and assessment of immunosuppressive agents Transplantation Proceedings 26(6): 3279
Francis, A.E.; Mirza, M. 1978: Analgesic agents. a spectrum of pediatric criteria Journal of the Kansas Medical Society 79(9): 494-497
Groeneveld, K.; van der Noordaa, J. 2005: Use of antiviral agents and other measures in an influenza pandemic Netherlands Journal of Medicine 63(9): 339-343